PureTech Health
Generated by Meeveem AI
"Unlocking new medicine classes to transform treatment for devastating diseases"
Boston, MA
•51 - 250 Employees
•Biotechnology
About PureTech Health
PureTech Health develops new classes of medicine for patients with devastating diseases where existing treatments fall short. The company starts with validated therapeutic approaches, then applies innovation to overcome limitations such as poor tolerability, low bioavailability, or off target effects. PureTech has generated 27 new therapeutics from its research engine, with three progressing to FDA approval. The portfolio spans immunology, lymphatic, and oncology therapeutics, addressing conditions including schizophrenia, pulmonary fibrosis, and mental health disorders. PureTech combines internal programmes with founded entities and partnerships, delivering clinical success rates six times higher than industry average.
56
Team Members
2005
Founded
Biotechnology
Sector
On-Site
Work Environment
Our Vision
A world where patients with devastating diseases access effective, tolerable treatments that unlock the full therapeutic potential of validated medicine classes previously limited by pharmacological barriers.
Our Mission
PureTech Health exists to give life to new classes of medicine by enhancing validated therapeutic approaches, enabling better outcomes for patients facing devastating diseases where current treatments fall short.